Download PDF
Thromb Haemost 1977; 38(02): 0399-0406
DOI: 10.1055/s-0038-1651475
Original Article
Schattauer GmbH

Platelet Coagulant Activities and Retinal Vein Thrombosis

Peter N. Walsh
1   Specialized Center on Thrombosis Research and Department of Medicine, Temple University Health Sciences Center Philadelphia, Pennsylvania 19140* and the Vascular Unit, Retina Service Wills Eye Hospital, Philadelphia, Pennsylvania 19130, U.S.A.
,
Richard E. Goldberg
1   Specialized Center on Thrombosis Research and Department of Medicine, Temple University Health Sciences Center Philadelphia, Pennsylvania 19140* and the Vascular Unit, Retina Service Wills Eye Hospital, Philadelphia, Pennsylvania 19130, U.S.A.
,
Richard L. Tax
1   Specialized Center on Thrombosis Research and Department of Medicine, Temple University Health Sciences Center Philadelphia, Pennsylvania 19140* and the Vascular Unit, Retina Service Wills Eye Hospital, Philadelphia, Pennsylvania 19130, U.S.A.
,
Larry E. Magargal
1   Specialized Center on Thrombosis Research and Department of Medicine, Temple University Health Sciences Center Philadelphia, Pennsylvania 19140* and the Vascular Unit, Retina Service Wills Eye Hospital, Philadelphia, Pennsylvania 19130, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 10 November 1976

Accepted 10 April 1977

Publication Date:
04 July 2018 (online)

    Permissions and Reprints

Summary

To determine whether platelets play a role in the pathogenesis of retinal vein occlusion (RVO), platelets and coagulation were evaluated in 28 patients with RVO. Platelet coagulant activities concerned with the initiation and early stages of intrinsic coagulation were 2–4 fold increased in 9 patients with acute primary RVO but not in patients with acute secondary (10 patients) or chronic (9 patients) RVO. Platelet factor 3 activity, platelet aggregation, serotonin release by platelets and plasma coagulation were normal in all patients. Platelets may provide a trigger mechanism for venous thrombosis in the eye when local conditions permit.

 

  • References

  • 1 Klein V. A, Olwin J. M. 1965; A survey of the pathogenesis of retinal venous occlusion. Archives of Ophthalmology 56: 207.
    PubMedGoogle Scholar
  • 2 Kok D.A, Watson P. G. 1976. Platelet aggregation in retinal vascular disease. In: Cant S. J. (Ed.) The William Mackensie Memorial Symposium on Vision and Circulation. C. V. Mosby and Company; St. Louis: 303.
    Google Scholar
  • 3 Kwaan H. C, Dobbie J. G, Fetkenhour C. L. 1976. The use of anticoagulants and thrombolytic agents in occlusive retinal vascular disease. In: Paoletti R, Sherry S. (Eds.) Thrombosis and Urokinase. Academic Press; London: in press.
    Google Scholar
  • 4 Lees R. S, Wilson D. E. 1971; The treatment of hyperlipidemia. New England Journal of Medicine 284: 186.
    CrossrefPubMedGoogle Scholar
  • 5 Lundblad R. L, Davie E. W. 1964; The activation of antihemophilic factor (factor VIII) by activated Christmas factor (activated factor IX). Biochemistry 3: 1720.
    CrossrefPubMedGoogle Scholar
  • 6 Milstone J. H. 1964; Thrombokinase as prime activator of prothrombin: Historical perspectives and present status. Federation Proceedings 23: 742.
    PubMedGoogle Scholar
  • 7 Pandolfi M, Isacson S, Åstedt B. 1972; Coagulation and fibrinolytic studies in 23 patients with occlusion of the retinal vessels. Acta Ophthalmologica 50: 62.
    PubMedGoogle Scholar
  • 8 Seitz R. 1964. The Retinal Vessels. C. V. Mosby and Company; St. Louis: 74.
    Google Scholar
  • 9 Walsh P. N. 1972; a The effect of dilution of plasma on coagulation. The significance of the dilution-activation phenomenon for the study of platelet coagulant activities. British Journal of Haematology 22: 219.
    CrossrefPubMedGoogle Scholar
  • 10 Walsh P. N. 1972; b The role of platelets in the contact phase of blood coagulation. British Jorunal of Haematology 22: 237.
    PubMedGoogle Scholar
  • 11 Walsh P. N. 1972; c The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XIII. British Journal of Haematology 22: 393.
    CrossrefPubMedGoogle Scholar
  • 12 Walsh P. N. 1972; d Platelet coagulant activities in thrombasthenia. British Journal of Haematology 23: 553.
    CrossrefPubMedGoogle Scholar
  • 13 Walsh P. N. 1974; Platelet coagulant activities and hemostasis: An hypothesis. Blood 43: 597.
    PubMedGoogle Scholar
  • 14 Walsh P. N, Biggs R. 1972; The role of platelets in intrinsic factor-Xa formation. British Journal of Haematology 22: 743.
    CrossrefPubMedGoogle Scholar
  • 15 Walsh P. N, Mills D. C. B, Pareti F. I, Stewart G. J, Macfarlane D. E, Johnson M. M, Egan J. J. 1975; Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. British Journal of Haematology 29: 639.
    CrossrefPubMedGoogle Scholar
  • 16 Walsh P. N, Pareti F. I, Corbett J. J. 1976; Platelet coagulant activities and serum lipids in transient cerebral ischemia. New England Journal of Medicine 295: 854.
    CrossrefPubMedGoogle Scholar
  • 17 Walsh P. N, Rogers P. H, Marder V. J, Gagnatelli G, Escovitz E. S, Sherry S. 1976; a The relationship of platelet coagulant activities to venous thrombosis following hip surgery. British Journal of Haematology 32: 423.
    PubMedGoogle Scholar
  • 18 Wessler S. 1955; Studies in intravascular coagulation III. The pathogenesis of serum-induced venous thrombosis. Journal of Clinical Investigation 34: 647.
    CrossrefPubMedGoogle Scholar
  • 19 Wise G. N, Dollery C. T, Henkind P. 1974. The Retinal Circulation. Harper and Row; New York.:
    Google Scholar